See more : UGRO Capital Limited (UGROCAP.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Bajaj HealthCare Limited (BAJAJHCARE.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bajaj HealthCare Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- SoftBank Group Corp. (SFTBY) Income Statement Analysis – Financial Results
- Gerresheimer AG (GXI.SW) Income Statement Analysis – Financial Results
- Quantum FinTech Acquisition Corporation (QFTA) Income Statement Analysis – Financial Results
- Enstar Group Limited (ESGRO) Income Statement Analysis – Financial Results
- E-Elements Technology Co., Ltd. (6842.TWO) Income Statement Analysis – Financial Results
Bajaj HealthCare Limited (BAJAJHCARE.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.bajajhealth.com
About Bajaj HealthCare Limited
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, and supplies amino acids, nutritional supplements, and active pharmaceutical ingredients (APIs) for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company's product portfolio consists of various APIs in the therapeutic categories of anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, anticonvulsant, lipotropic agents, nootropic, vasoprotective/ antihemorrhagic, cardiovascular agent, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It also provides formulations in the form of tablets, capsules, and powder, as well as impurities. In addition, the company exports its products. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.73B | 6.73B | 6.79B | 6.56B | 3.59B | 3.23B | 2.87B | 2.31B | 2.23B | 2.18B | 2.05B | 1.71B | 1.42B | 1.20B |
| Cost of Revenue | 2.59B | 4.91B | 4.95B | 4.63B | 2.64B | 2.82B | 2.16B | 1.72B | 1.67B | 1.68B | 1.65B | 1.39B | 1.13B | 760.65M |
| Gross Profit | 2.14B | 1.83B | 1.84B | 1.93B | 948.25M | 413.61M | 709.15M | 581.71M | 562.63M | 507.30M | 402.86M | 314.19M | 288.23M | 437.96M |
| Gross Profit Ratio | 45.26% | 27.13% | 27.07% | 29.41% | 26.39% | 12.80% | 24.70% | 25.22% | 25.25% | 23.24% | 19.66% | 18.40% | 20.37% | 36.54% |
| Research & Development | 16.28M | 38.00M | 26.15M | 45.32M | 22.30M | 0.00 | 13.66M | 11.55M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 57.37M | 478.37M | 69.57M | 55.71M | 27.20M | 32.12M | 23.42M | 29.03M | 28.42M | 144.53M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 96.71M | 9.55M | 939.00K | 5.66M | 4.73M | 1.40M | 3.32M | 6.74M | 9.01M | 1.32M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 154.07M | 487.92M | 70.51M | 61.37M | 31.94M | 33.52M | 26.75M | 35.77M | 37.43M | 145.85M | 125.75M | 109.10M | 0.00 | 0.00 |
| Other Expenses | 1.99B | 15.98M | 2.54M | 13.76M | 2.19M | 1.53M | 396.19M | 350.75M | 305.94M | 308.86M | 298.82M | 267.18M | 231.51M | 347.90M |
| Operating Expenses | 2.14B | 1.03B | 797.11M | 716.42M | 517.72M | 477.13M | 422.94M | 386.52M | 343.37M | 308.86M | 298.82M | 267.18M | 231.51M | 347.90M |
| Cost & Expenses | 4.67B | 5.94B | 5.75B | 5.35B | 3.16B | 3.30B | 2.58B | 2.11B | 2.01B | 1.98B | 1.95B | 1.66B | 1.36B | 1.11B |
| Interest Income | 2.61M | 2.38M | 1.72M | 1.67M | 3.09M | 2.49M | 1.57M | 745.33K | 509.81K | 600.00K | 827.00K | 740.00K | 439.00K | 1.17M |
| Interest Expense | 296.80M | 228.72M | 127.82M | 83.37M | 49.94M | 71.10M | 66.35M | 71.93M | 68.87M | 78.90M | 71.98M | 63.27M | 46.85M | 42.10M |
| Depreciation & Amortization | 276.20M | 273.55M | 176.37M | 161.24M | 121.23M | 114.10M | 110.83M | 113.46M | 92.90M | 88.61M | 89.47M | 81.07M | 56.08M | 47.11M |
| EBITDA | 406.24M | 1.13B | 1.22B | 1.39B | 554.87M | 459.67M | 394.94M | 310.55M | 313.39M | 287.67M | 194.34M | 129.02M | 113.45M | 147.83M |
| EBITDA Ratio | 8.58% | 16.11% | 17.70% | 21.85% | 14.28% | 13.15% | 14.15% | 13.99% | 13.35% | 13.18% | 9.48% | 7.54% | 8.00% | 12.20% |
| Operating Income | 6.26M | 821.91M | 1.04B | 1.23B | 433.64M | 345.57M | 286.21M | 195.19M | 219.26M | 198.44M | 104.04M | 47.01M | 56.72M | 90.06M |
| Operating Income Ratio | 0.13% | 12.21% | 15.36% | 18.69% | 12.07% | 10.69% | 9.97% | 8.46% | 9.84% | 9.09% | 5.08% | 2.75% | 4.01% | 7.51% |
| Total Other Income/Expenses | -173.02M | -1.36B | -468.74M | -292.93M | -106.01M | -102.60M | -248.02M | -58.29M | -84.27M | -78.20M | -71.06M | -62.26M | -46.39M | -31.52M |
| Income Before Tax | -166.76M | 582.16M | 896.85M | 1.19B | 324.51M | 241.70M | 226.85M | 136.90M | 134.99M | 120.17M | 32.89M | -15.32M | 10.51M | 58.62M |
| Income Before Tax Ratio | -3.52% | 8.65% | 13.20% | 18.12% | 9.03% | 7.48% | 7.90% | 5.94% | 6.06% | 5.50% | 1.61% | -0.90% | 0.74% | 4.89% |
| Income Tax Expense | -23.49M | 151.92M | 182.99M | 357.11M | 99.52M | 78.59M | -74.98M | 58.65M | 52.99M | 45.02M | 13.18M | -4.76M | 4.01M | 13.89M |
| Net Income | -837.93M | 430.24M | 713.86M | 831.09M | 252.37M | 163.10M | 151.86M | 78.25M | 82.00M | 75.15M | 19.71M | -10.56M | 6.50M | 44.73M |
| Net Income Ratio | -17.70% | 6.39% | 10.51% | 12.67% | 7.02% | 5.05% | 5.29% | 3.39% | 3.68% | 3.44% | 0.96% | -0.62% | 0.46% | 3.73% |
| EPS | -30.36 | 15.59 | 25.87 | 30.11 | 9.14 | 5.91 | 5.50 | 2.84 | 3.04 | 2.78 | 0.73 | -0.39 | 0.24 | 1.66 |
| EPS Diluted | -30.36 | 15.59 | 25.87 | 30.11 | 9.14 | 5.91 | 5.50 | 2.84 | 3.04 | 2.78 | 0.73 | -0.39 | 0.24 | 1.66 |
| Weighted Avg Shares Out | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M | 27.54M | 27.00M | 27.00M | 27.00M | 27.00M | 27.00M | 27.00M |
| Weighted Avg Shares Out (Dil) | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M | 27.54M | 27.00M | 27.00M | 27.00M | 27.00M | 27.00M | 27.00M |
Source: https://incomestatements.info
Category: Stock Reports